Schonfeld Strategic Advisors LLC Bristol Myers Squibb CO Transaction History
Schonfeld Strategic Advisors LLC
- $15.2 Billion
- Q3 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 1,178,101 shares of BMY stock, worth $55.1 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
1,178,101
Previous 25,818
4463.1%
Holding current value
$55.1 Million
Previous $1.2 Million
4346.19%
% of portfolio
0.35%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...